Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies

References

• Ackermann HW, Krisch HM. 1997. A catalogue of T4-type bacteriophages. Arch Virol. 142:2329–2345.
   PubMed Web of Science ®Google Scholar
• Aslam S, Trautner BW, Ramanathan V, Darouiche RO. 2007. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother. 51:1556–1558.
   PubMed Web of Science ®Google Scholar
• Aswani V, Tremblay DM, Moineau S, Shukla SK. 2011. Staphylococcus epidermidis bacteriophages from the anterior nares of humans. Appl Environ Microbiol. 77:7853–7855.
   PubMed Web of Science ®Google Scholar
• Azeredo J, Sutherland IW. 2008. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol. 9:261–266.
   PubMed Web of Science ®Google Scholar
• Bes M. 1994. Characterization of thirteen Staphylococcus epidermidis and S. saprophyticus bacteriophages. Res Virol. 145:111–121.
   PubMedGoogle Scholar
• Beveridge T, Makin S, Kadurugamuwa J, Li Z. 1997. Interactions between biofilms and the environment. FEMS Microbiol Rev. 20:291–303.
   PubMed Web of Science ®Google Scholar
• Bridier A, Briandet R, Thomas V, Dubois-Brissonnet F. 2011. Resistance of bacterial biofilms to disinfectants: a review. Biofouling. 27:1017–1032.
   PubMed Web of Science ®Google Scholar
• Bruttin A, Brussow H. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 49:2874–2878.
   PubMed Web of Science ®Google Scholar
• Carneiro VA, Santos HS, Arruda FVS, Bandeira PN, Albuquerque MRJR, Pereira MO, Henriques M, Cavada BS, Teixeira EH. 2011. Casbane diterpene as a promising natural antimicrobial agent against biofilm associated infections. Molecules. 16:190–201.
   Web of Science ®Google Scholar
• Cerca N, Jefferson MK, Oliveira R, Pier GB, Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun. 74:4849–4855.
   PubMed Web of Science ®Google Scholar
• Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J. 2005. Comparative assessment of antibiotic susceptibility of coagulase-negative Staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 56:331–336.
   PubMed Web of Science ®Google Scholar
• Cerca N, Oliveira R, Azeredo J. 2007. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol. 45:313–317.
   PubMed Web of Science ®Google Scholar
• Chi CY, Wong WW, Fung CP, Yu KW, Liu CY. 2004. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect. 37:16–23.
   PubMedGoogle Scholar
• Chibani-Chennoufi S, Dillmann ML, Marvin-Guy L, Rami-Shojaei S, Brussow H. 2004. Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol. 186:7069–7083.
   PubMed Web of Science ®Google Scholar
• Costerton JW. 1995. Overview of microbial biofilms. J Ind Microbiol. 15:137–140.
   PubMedGoogle Scholar
• Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322.
   PubMed Web of Science ®Google Scholar
• Cramton SE, Ulrich M, Götz F, Döring G. 2001. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun. 69:4079–4085.
   PubMed Web of Science ®Google Scholar
• Curtin JJ, Donlan RM. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother. 50:1268–1275.
   PubMed Web of Science ®Google Scholar
• Daniel A, Bonnen PE, Fischetti VA. 2007. First complete genome sequence of two Staphylococcus epidermidis bacteriophages. J Bacteriol. 189:2086–2100.
   PubMed Web of Science ®Google Scholar
• Decousser JW, Bourgeois-Nicolaos N, Doucet-Populaire F. 2007. Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug resistant Gram-positive bacteria. Expert Rev Anti Infect Ther. 5:557–571.
   PubMed Web of Science ®Google Scholar
• Deghorain M, Melderen LV. 2012. The staphylococci phages family: an overview. Viruses. 4:3316–3335.
   PubMed Web of Science ®Google Scholar
• Derengowski LS, De-Souza-Silva C, Braz SV, Mello-De-Sousa TM, Báo SN, Kyaw CM, Silva-Pereira I. 2009. Antimicrobial effect of farnesol, a Candida albicans quorum-sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob. 8:13.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach MSENTRY Participants Group. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 32:S114–S132.
   PubMed Web of Science ®Google Scholar
• Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB. 2007. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 51:2733–2740.
   PubMed Web of Science ®Google Scholar
• Donlan RM. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 17:66–72.
   PubMed Web of Science ®Google Scholar
• Doolittle MM, Cooney JJ, Caldwell DE. 1996. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol. 16:331–341.
   PubMedGoogle Scholar
• Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. 1997. Oral treatment of Staphylococcus spp. infected orthopedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother. 39:235–240.
   PubMed Web of Science ®Google Scholar
• Duguid IG, Evans E, Brown MR, Gilbert P. 1992a. Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrob Chemother. 30:803–810.
   PubMed Web of Science ®Google Scholar
• Duguid IG, Evans E, Brown MR, Gilbert P. 1992b. Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis: evidence for cell-cycle dependency. J Antimicrob Chemother. 30:791–802.
   PubMed Web of Science ®Google Scholar
• El-Azizi M, Rao S, Kanchanapoom T, Khardori N. 2005. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of Staphylococci. Ann Clin Microbiol Antimicrob. 4:2.
   PubMedGoogle Scholar
• Fabian D, Sabol M, Domaracka K, Bujnáková D. 2006. Essential oils – their antimicrobial activity against Escherichia coli and effect on intestinal cell viability. Toxicol in Vitro. 20:1435–1445.
   PubMed Web of Science ®Google Scholar
• Fischetti VA. 2010. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol. 300:357–362.
   PubMed Web of Science ®Google Scholar
• Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH. 2005. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 49:3858–3867.
   PubMed Web of Science ®Google Scholar
• Gomes F, Leite B, Teixeira P, Azeredo J, Oliveira R. 2012. Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells. Braz J Microbiol. 43:235–242.
   PubMed Web of Science ®Google Scholar
• Gomes F, Teixeira P, Cerca N, Azeredo J, Oliveira R. 2011. Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Curr Microbiol. 63:354–359.
   PubMed Web of Science ®Google Scholar
• Gomes F, Teixeira P, Cerca N, Ceri H, Oliveira R. 2011. Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics. Microb Drug Resist. 17:191–196.
   PubMed Web of Science ®Google Scholar
• Gomes F, Teixeira P, Ceri H, Oliveira R. 2012. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms. Indian J Med Res. 135:542–547.
   PubMed Web of Science ®Google Scholar
• Gomes FI, Leite B, Teixeira P, Cerca N, Azeredo J, Oliveira R. 2011. Farnesol as antibiotics adjuvant in Staphylococcus epidermidis control in vitro. Am J Med Sci. 341:191–195.
   PubMed Web of Science ®Google Scholar
• Gomes FIA, Teixeira P, Azeredo J, Oliveira R. 2009. Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol. 59:118–122.
   PubMed Web of Science ®Google Scholar
• Götz F. 2004. Staphylococci in colonisation and disease: prospective targets for drugs and vaccines. Curr Opin Microbiol. 7:477–487.
   PubMed Web of Science ®Google Scholar
• Gutiérrez D, Martínez B, Rodríguez A, García P. 2010. Isolation and characterization of bacteriophages infecting Staphylococcus epidermidis. Curr Microbiol. 61:601–608.
   PubMed Web of Science ®Google Scholar
• Gutiérrez D, Martínez B, Rodríguez A, Garcia P. 2012. Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential. BMC Genomics. 13:228.
   PubMedGoogle Scholar
• Hajdu S, Lassnigg A, Graninger W, Hirschl AM, Presterl E. 2009. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthopaed Res. 27:1361–1365.
   PubMed Web of Science ®Google Scholar
• Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. 2001. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 67:2746–2753.
   PubMed Web of Science ®Google Scholar
• Hanssen AM, Kjeldsen G, Sollid JU. 2004. Local variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci: evidence of horizontal gene transfer? Antimicrob Agents Chemother. 48:285–296.
   PubMed Web of Science ®Google Scholar
• Haque N, Hossain MA, Bilkis L, Musa AK, Mahamud C, Bari MS, Haque N, Muhammad N, Paryin US, Islam MT, et al. 2009. Antibiotic susceptibility pattern of Staphylococcus epidermidis. Mymensingh Med J. 18:142–147.
   PubMedGoogle Scholar
• Harro JM, Peters BM, O’May GA, Archer N, Kerns P, Prabhara R, Shirtliff ME. 2010. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol. 59:306–323.
   PubMed Web of Science ®Google Scholar
• Hellmark B, Unemo M, Nilsdotter-Augustinsson Å, Söderquist B. 2009. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin Microbiol Infect. 15:238–244.
   PubMed Web of Science ®Google Scholar
• Hughes KA, Sutherland IW, Jones MV. 1998. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology. 144:3039–3047.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Shiraishi A, Hada T, Hirose K, Hamashima H, Shimada J. 2004. The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol Lett. 237:325–331.
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. 2006. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother. 50:1463–1469.
   PubMed Web of Science ®Google Scholar
• Ji G, Beavis R, Novick RP. 1997. Bacterial interference caused by autoinducing peptide variants. Science. 276:2027–2030.
   PubMed Web of Science ®Google Scholar
• Johnson AP, Tysall L, Stockdale MV, Woodford N, Kaufmann ME, Warner M, Livermore DM, Asboth F, Allerberger FJ. 2002. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis. 21:751–754.
   PubMed Web of Science ®Google Scholar
• Kaplan JB. 2011. Antibiotic-induced biofilm formation. Int J Artif Organs. 34:737–751.
   PubMed Web of Science ®Google Scholar
• Kaplan JB, Jabbouri S, Sadovskaya I. 2011. Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res Microbiol. 162:525–541.
   Google Scholar
• Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N. 2004. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 48:2633–2636.
   PubMed Web of Science ®Google Scholar
• Kelly-Quintos C, Cavacini LA, Posner MR, Goldmann D, Pier GB. 2006. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun. 74:2742–2750.
   PubMed Web of Science ®Google Scholar
• Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett. 230:13–18.
   PubMed Web of Science ®Google Scholar
• Khardori N, Yassien M, Wilson K. 1995. Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents. J Ind Microbiol. 15:148–151.
   PubMedGoogle Scholar
• Kiedrowski MR, Horswill AR. 2011. New approaches for treating staphylococcal biofilm infections. Ann NY Acad Sci. 1241:104–121.
   PubMed Web of Science ®Google Scholar
• Knobloch JKM, Horstkotte MA, Rohde H, Kaulfers PM, Mack D. 2002. Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother. 49:683–687.
   PubMed Web of Science ®Google Scholar
• Kocianova S, Vuong C, Yao Y, Voyich JM, Fischer ER, DeLeo FR, Otto M. 2005. Key role of poly-γ-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest. 115:688–694.
   PubMed Web of Science ®Google Scholar
• Kutateladze M, Adamia R. 2010. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28:591–595.
   PubMed Web of Science ®Google Scholar
• Kuźma Ł, Różalski M, Walencka E, Rózalska B, Wysokińska H. 2007. Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine. 14:31–35.
   PubMed Web of Science ®Google Scholar
• Kvist M, Hancock V, Klemm P. 2008. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol. 74:7376–7382.
   PubMed Web of Science ®Google Scholar
• Labthavikul P, Petersen PJ, Bradford PA. 2003. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother. 47:3967–3969.
   PubMed Web of Science ®Google Scholar
• Leite B, Gomes F, Teixeira P, Souza C, Pizzolitto E, Oliveira R. 2011a. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol. 63:313–317.
   PubMed Web of Science ®Google Scholar
• Leite B, Gomes F, Teixeira P, Souza C, Pizzolitto E, Oliveira R. 2011b. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin. Am J Ther. 42:1312–1314.
   Google Scholar
• Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, Laufs R. 1996. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol. 178:175–183.
   PubMed Web of Science ®Google Scholar
• Madhusoodanan J, Seo KS, Remortel B, Park JY, Hwang SY, Fox LK, Park YH, Deobald CF, Wang D, Liu S, et al. 2011. An enterotoxin-bearing pathogenicity island in Staphylococcus epidermidis. J Bacteriol. 193:1854–1862.
   PubMed Web of Science ®Google Scholar
• Maira-Litran T, Kropec A, Goldmann D, Pier GB. 2004. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 22:872–879.
   PubMed Web of Science ®Google Scholar
• McCann MT, Gilmore BF, Gorman SP. 2008. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmacol. 60:1551–1571.
   PubMed Web of Science ®Google Scholar
• McKenney D, Pouliot K, Wang Y, Murthy V, Ulrich M, Döring G, Lee JC, Goldmann DA, Pier GB. 2000. Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis. J Biotechnol. 83:37–44.
   PubMed Web of Science ®Google Scholar
• Mick V, Dominguez MA, Tubau F. 2010. Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228, Spain. BMC Microbiol. 10:68.
   PubMedGoogle Scholar
• Moellering RC. 2008. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 46:1032–1037.
   PubMed Web of Science ®Google Scholar
• Monzón M, Oteiza C, Leiva J, Amorena B. 2001. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother. 48:793–801.
   PubMed Web of Science ®Google Scholar
• Monzote L, Montalvo AM, Scull R, Miranda M, Abreu J. 2007. Activity, toxicity and analysis of resistance of essential oil from Chenopodium ambrosioides after intraperitoneal, oral and intralesional administration in BALB/c mice infected with Leishmania amazonensis: a preliminary study. Biomed Pharmacother. 61:148–153.
   PubMed Web of Science ®Google Scholar
• Novick RP, Subedi A. 2007. The SaPIs: mobile pathogenicity islands of Staphylococcus. Chem Immunol Allergy. 93:42–57.
   PubMedGoogle Scholar
• Nuryastuti T, van der Mei HC, Busscher HJ, Iravati S, Aman AT, Krom BP. 2009. Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis. Appl Environ Microb. 75:6850–6855.
   PubMed Web of Science ®Google Scholar
• O’Flaherty S, Ross RP, Meaney W, Fitzgerald GF, Elbreki MF, Coffey A. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant Staphylococci from hospitals. Appl Environ Microbiol. 71:1836–1842.
   PubMed Web of Science ®Google Scholar
• Olofsson A-C, Hermansson M, Elwing H. 2003. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol. 69:4814–4822.
   PubMed Web of Science ®Google Scholar
• Otto M. 2008. Staphylococcal biofilms. Curr Top Microbiol Immunol. 322:207–228.
   PubMed Web of Science ®Google Scholar
• Otto M. 2009. Staphylococcus epidermidis – the ‘accidental pathogen’. Nat Rev Microbiol. 7:555–567.
   PubMed Web of Science ®Google Scholar
• Otto M, Süßmuth R, Vuong C, Jung G, Götz F. 1999. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 450:257–262.
   PubMed Web of Science ®Google Scholar
• Paterson DL. 1999. Reduced susceptibility of Staphylococcus aureus to vancomycin – a review of current knowledge. Commun Dis Intell. 23:69–73.
   PubMedGoogle Scholar
• Pei L, Flock JI. 2001. Functional study of antibodies against a fibrogenin-binding protein in Staphylococcus epidermidis adherence to polyethylene catheters. J Infect Dis. 184:52–55.
   PubMed Web of Science ®Google Scholar
• Piette A, Verschraegen G. 2009. Role of coagulase-negative staphylococci in human disease. Vet Microbiol. 134:45–54.
   PubMed Web of Science ®Google Scholar
• Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, Gold HS. 2002. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis. 186:1603–1607.
   PubMed Web of Science ®Google Scholar
• Prabuseenivasan S, Jayakumar M, Ignacimuthu S. 2006. In vitro antibacterial activity of some plant essential oils. BMC Complem Altern M. 6:39.
   PubMedGoogle Scholar
• Projan SJ, Nesin M, Dunman PM. 2006. Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Curr Opin Pharmacol. 6:473–479.
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. 2007. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 51:1656–1660.
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Maki D. 2007. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 7:645–657.
   PubMed Web of Science ®Google Scholar
• Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W. 2000. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother. 44:3357–3363.
   PubMed Web of Science ®Google Scholar
• Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR, Flock JI. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine. 19:3376–3383.
   PubMed Web of Science ®Google Scholar
• Riise GC, Qvarfordt I, Larsson S, Eliasson V, Andersson BA. 2000. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration. 67:552–558.
   PubMed Web of Science ®Google Scholar
• Rogers KL, Fey PD, Rupp ME. 2009. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am. 23:73–98.
   PubMed Web of Science ®Google Scholar
• Saginur R, St. Denis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K. 2006. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother. 50:55–61.
   PubMed Web of Science ®Google Scholar
• Shahrooei M, Hira V, Khodaparast L, Khodaparast L, Stijlemans B, Kucharíková S, Burghout P, Hermans PWM, Van Eldere J. 2012. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect Immun. 80:3660–3668.
   PubMed Web of Science ®Google Scholar
• Shan B, Cai John YZ, Corke H. 2007. Antibacterial properties and major bioactive components of cinnamon stick (Cinnamon burmannii): activity against foodborne pathogenic bacteria. J Agri Food Chem. 55:5484–5490.
   PubMed Web of Science ®Google Scholar
• Sillankorva S, Oliveira R, Vieira M, Sutherland IW, Azeredo J. 2004. Bacteriophage ξ-S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling. 20:133–138.
   PubMed Web of Science ®Google Scholar
• Sousa C, Henriques M, Oliveira R. 2011. Mini-review: antimicrobial central venous catheters – recent advances and strategies. Biofouling. 27:609–620.
   PubMedGoogle Scholar
• Srinivasan S, Sheela D, Shashikala, Mathew R, Bazroy J, Kanungo R. 2006. Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus. Indian J Med Microbiol. 24:182–185.
   PubMedGoogle Scholar
• Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. 2000. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J. 16:253–262.
   PubMed Web of Science ®Google Scholar
• Sulakvelidze A, Kutter E. 2005. Bacteriophage therapy in humans. In: Kutter E, Sulakvelidze A, editors. Bacteriophages: biology and application. Boca Raton (FL): CRC Press; p. 381–436.
   Google Scholar
• Sun DQ, Accavitti MA, Bryers JD. 2005. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol. 12:93–100.
   PubMedGoogle Scholar
• Van Mellaert L, Shahrooei M, Dorien Hofmans D, Van Eldere J. 2012. Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. Expert Rev Vaccines. 11:319–334.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun FJ, Liu Y, Xiong L-R, Xie L-L, Xia P-Y. 2010. Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive- and negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother. 54:2707–2711.
   PubMed Web of Science ®Google Scholar
• Wang X, Yao X, Zhu Z, Tang T, Dai K, Sadovskaya I, Flahaut S, Jabbouri S. 2009. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agents. 34:60–66.
   PubMed Web of Science ®Google Scholar
• Yao Y, Sturdevant DE, Otto M. 2005. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis. 191:289–298.
   PubMed Web of Science ®Google Scholar
• Zavasky DM, Sande MA. 1998. Reconsideration of rifampin: a unique drug for a unique infection. J Am Med Assoc. 279:1575–1577.
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmet AF, Blatter M, Frei R, Ochsner PE. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. J Am Med Assoc. 279:1537–1541.
   PubMed Web of Science ®Google Scholar